These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25521923)

  • 1. Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients.
    Valverde-Filho J; da Cunha Neto MB; Fonoff ET; Meirelles Ede S; Teixeira MJ
    Pain Med; 2015 Apr; 16(4):715-25. PubMed ID: 25521923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine consequences of long-term intrathecal administration of opioids.
    Abs R; Verhelst J; Maeyaert J; Van Buyten JP; Opsomer F; Adriaensen H; Verlooy J; Van Havenbergh T; Smet M; Van Acker K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2215-22. PubMed ID: 10852454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism in patients treated with intrathecal morphine.
    Finch PM; Roberts LJ; Price L; Hadlow NC; Pullan PT
    Clin J Pain; 2000 Sep; 16(3):251-4. PubMed ID: 11014399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
    Daniell HW
    J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment.
    Rhodin A; Stridsberg M; Gordh T
    Clin J Pain; 2010 Jun; 26(5):374-80. PubMed ID: 20473043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis.
    Palm S; Moenig H; Maier C
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):269-73. PubMed ID: 9228653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of opioid therapy on endocrine function.
    Brennan MJ
    Am J Med; 2013 Mar; 126(3 Suppl 1):S12-8. PubMed ID: 23414717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and hypogonadism.
    Prescrire Int; 2012 Apr; 21(126):98-9. PubMed ID: 22515135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of intrathecal opioids in chronic non-cancer pain.
    Roberts LJ; Finch PM; Goucke CR; Price LM
    Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine consequences of opioid therapy.
    Aloisi AM; Aurilio C; Bachiocco V; Biasi G; Fiorenzani P; Pace MC; Paci V; Pari G; Passavanti G; Ravaioli L; Sindaco G; Vellucci R; Ceccarelli I
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S162-8. PubMed ID: 19540049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic use of opioid medications before and after bariatric surgery.
    Raebel MA; Newcomer SR; Reifler LM; Boudreau D; Elliott TE; DeBar L; Ahmed A; Pawloski PA; Fisher D; Donahoo WT; Bayliss EA
    JAMA; 2013 Oct; 310(13):1369-76. PubMed ID: 24084922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deficiency in long-term intrathecal opioid administration.
    Kim CH; Garcia R; Stover J; Ritchie K; Whealton T; Ata MA
    Pain Physician; 2014; 17(4):E543-8. PubMed ID: 25054405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Related Endocrinopathy.
    Gudin JA; Laitman A; Nalamachu S
    Pain Med; 2015 Oct; 16 Suppl 1():S9-15. PubMed ID: 26461076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
    Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
    Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrathecal opioid administration on pituitary function.
    Xenidis M; Pandya N; Hames E
    Pain Med; 2013 Nov; 14(11):1741-4. PubMed ID: 23870183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management in patients with adolescent idiopathic scoliosis undergoing posterior spinal fusion: combined intrathecal morphine and continuous epidural versus PCA.
    Ravish M; Muldowney B; Becker A; Hetzel S; McCarthy JJ; Nemeth BA; Noonan KJ
    J Pediatr Orthop; 2012 Dec; 32(8):799-804. PubMed ID: 23147623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.